Lack of effect of antacids on single-dose pharmacokinetics of etoricoxib.
Schwartz
Jules I
JI
Merck Research Laboratories, Merck and Co Inc., 126 East Lincoln Avenue, PO Box 2000, RY34-A552, Rahway, NJ 07065-0900, USA.
Agrawal
Nancy G B
NG
Kher
Uma A
UA
DeSmet
Marina
M
Cavanaugh
Paul F
PF
Guillaume
Michel
M
Ebel
David L
DL
Merschman
Shelia A
SA
Wagner
John A
JA
D000328:Adult; D000368:Aged; D000536:Aluminum Hydroxide / Q000494:pharmacology; D000704:Analysis of Variance; D000863:Antacids / Q000494:pharmacology*; D019540:Area Under Curve; D002119:Calcium Carbonate / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D004347:Drug Interactions; D000077613:Etoricoxib; D005260:Female; D006801:Humans; D008276:Magnesium Hydroxide / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D013450:Sulfones / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*
D000863:Antacids; D016861:Cyclooxygenase Inhibitors; D011725:Pyridines; D013450:Sulfones; D000536:Aluminum Hydroxide; D002119:Calcium Carbonate; D008276:Magnesium Hydroxide; D000077613:Etoricoxib